Novartis has bought Vedere Bio, a retinal disease therapy spinout of UC Berkeley also exploiting UPenn research, to expand its gene medicine capabilities.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Miyako Capital has participated in the second close of an $11.4m round Floadia, whose investors already include Innovations and Future Creation.

Alexis Dormandy will join Oxford Sciences Innovation as chief executive, moving over from Atomico by January 2021 to take over from interim CEO Jim Wilkinson.

Arkansas has lured Weston Waldo, an innovation professional with expertise at I-Corps, to run its venture development programming.

HBCU Seed will invest in eligible startups from US historically black colleges and universities at a time of heightened tension over racial inequalities.

MIT has put $35m into The Engine's second fund – up from its $25m commitment to the first fund – and has been joined by Harvard as a new LP.

Exact Sciences has shelled out $410m to buy University of Oxford early cancer test company Base Genomics, incorporated in July 2019.

Exact Sciences is set to acquire Johns Hopkins spinout Thrive Earlier Detection for up to $2.15bn in cash and stock, including $1.7bn upfront.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.